Monika Licaj et al.
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Nature Communications 2024, vol. 15, issue 1
doi: 10.1038/s41467-024-45595-3